SUPIME


Supime (Cefepime Hydrochloride plus Sulbactam Sodium) tackles growing ESBL resistance to Cefepime and other cephalosporins.

Indications

  • Lower respiratory tract infections (LRTI; Nosocomial and community acquired pneumonia)
  • Complicated urinary tract infections (UTI; including pyelonephritis)
  • Mild to moderate bacterial septicemia

Product Presentation

1.5 /3.0 g dry powder for Intravenous (IV) or Intramuscular (IM) Injection









Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to VRL India, its subsidiaries or affiliates. No use of any VRL India trademark, trade name, or trade dress in this site may be made without the prior written authorization of VRL India, except to identify the product or services of the company.

Back to Top